Interest Expense On Debt Veränderung Datum
AbbVie USD 700M 90M 2025-03
Adma Biologics USD 2.88M 620K 2024-12
Amgen USD 723M 24M 2025-03
AstraZeneca 303M 126M 2025-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Bristol-Myers Squibb USD 485M 9M 2025-06
Dynavax Technologies USD 1.69M 12K 2025-03
Gilead Sciences USD 260M 12M 2025-03
Glaxosmithkline 178.05M 24.73M 2024-12
Merck USD 305M 8M 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 289M 19M 2025-06
Pfizer USD 654M 85M 2025-03
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 4.5M 415K 2025-03
TG Therapeutics USD 10.83M 6.86M 2024-09
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12


Dynavax Technologies Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.